Clinical trial
Safety and Efficacy of Low Temperature Contrast for the Treatment of PCI-related Myocardial Injury in Patients With Unstable Angina Pectoris (LOTA-I)
NCT03700567 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Low Temperature Contrast for the Treatment of PCI-related Myocardial Injury in Patients With Unstable Angina Pectoris (LOTA-I)
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2018
- Completion date
- July 1, 2023
- Enrollment
- 440 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
unstable angina pectoris